SEC Form 4 · accession 0001140361-15-045045
BIOLASE, INC · BIOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Nov 24, 2015
Accepted (ET)
Dec 18, 2015 · 11:30 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F1 | Nov 24, 2015 | P | 100 | $0.92 | A | 5,885,703 | I | By Trust |
| Common StockF2,F1 | Nov 25, 2015 | P | 44,200 | $0.90 | A | 5,929,903 | I | By Trust |
| Common StockF2,F1 | Nov 26, 2015 | P | 2,045 | $0.89 | A | 5,931,948 | I | By Trust |
| Common StockF2,F1 | Nov 30, 2015 | P | 16,752 | $0.90 | A | 5,948,700 | I | By Trust |
| Common StockF2,F1 | Dec 2, 2015 | P | 5,900 | $0.85 | A | 5,954,600 | I | By Trust |
| Common StockF2,F1 | Dec 3, 2015 | P | 16,427 | $0.81 | A | 5,971,027 | I | By Trust |
| Common StockF2,F1 | Dec 4, 2015 | P | 5,286 | $0.81 | A | 5,976,313 | I | By Trust |
| Common StockF2,F1 | Dec 7, 2015 | P | 8,561 | $0.80 | A | 5,984,874 | I | By Trust |
| Common StockF2,F1 | Dec 8, 2015 | P | 14,596 | $0.79 | A | 5,999,470 | I | By Trust |
| Common StockF2,F1 | Dec 9, 2015 | P | 5,704 | $0.79 | A | 6,005,174 | I | By Trust |
| Common StockF2,F1 | Dec 10, 2015 | P | 31,699 | $0.78 | A | 6,036,873 | I | By Trust |
| Common StockF2,F1 | Dec 11, 2015 | P | 7,078 | $0.77 | A | 6,043,951 | I | By Trust |
| Common StockF2,F1 | Dec 14, 2015 | P | 42,923 | $0.74 | A | 6,086,874 | I | By Trust |
| Common StockF2,F1 | Dec 15, 2015 | P | 28,000 | $0.72 | A | 6,114,874 | I | By Trust |
| Common Stock | holding | — | — | — | 14,800 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are held by the Jack W. Schuler Living Trust (the "Trust"). Mr. Schuler serves as sole trustee to the Trust.
- F2The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices within a $1.00 range. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price for each transaction reported in this Form 4.